
Intracellular IFN-γ and IL-2 expression monitoring as surrogate markers of the risk of acute rejection and personal drug response in de novo liver transplant recipients
Keywords: برفلدین A; AR; acute rejection; BPAR; biopsy-proven acute rejection; CNi; calcineurin inhibitor; PBS; phosphate buffered saline; FCS; fetal calf serum; ConA; concanavalin A; BFA; brefeldin A; PMA; phorbol 12 myristate 13-acetate; Io; ionomycin; IL; interleukin; IFN;